A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor …

FG Herrera, P Chan, C Doll, M Milosevic, A Oza… - International Journal of …, 2007 - Elsevier
Purpose: To evaluate the toxicity and effectiveness of celecoxib in combination with
definitive chemoradiotherapy (CRT) in women with locally advanced cervical cancer …
被引用次数：83 相关文章

A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor …

FG Herrera, P Chan, C Doll, M Milosevic… - … Journal of Radiation …, 2006 - europepmc.org
A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with
carcinoma of the cervix with biomarker assessment of the tumor microenvironment …

A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor …

FG Herrera, P Chan, C Doll, M Milosevic… - International Journal of …, 2007 - inis.iaea.org
[en] Purpose: To evaluate the toxicity and effectiveness of celecoxib in combination with
definitive chemoradiotherapy (CRT) in women with locally advanced cervical cancer …
[PDF] academia.edu

[PDF][PDF] A PROSPECTIVE PHASE I–II TRIAL OF THE CYCLOOXYGENASE-2 INHIBITOR CELECOXIB IN PATIENTS WITH CARCINOMA OF THE CERVIX WITH …

FG HERRERA, P CHAN, C DOLL… - Int. J. Radiation …, 2007 - academia.edu
Purpose: To evaluate the toxicity and effectiveness of celecoxib in combination with
definitive chemoradiotherapy (CRT) in women with locally advanced cervical cancer …

A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor …

FG Herrera, P Chan, C Doll, M Milosevic, A Oza… - International Journal of …, 2007 - osti.gov
Purpose: To evaluate the toxicity and effectiveness of celecoxib in combination with
definitive chemoradiotherapy (CRT) in women with locally advanced cervical cancer …

A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor …

FG Herrera, P Chan, C Doll, M Milosevic… - International Journal of …, 2007 - redjournal.org
Purpose: To evaluate the toxicity and effectiveness of celecoxib in combination with
definitive chemoradiotherapy (CRT) in women with locally advanced cervical cancer …

A prospective phase I–II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor …

FG Herrera, P Chan, C Doll, M Milosevic, A Oza… - International Journal of …, 2007 - infona.pl
Purpose: To evaluate the toxicity and effectiveness of celecoxib in combination with
definitive chemoradiotherapy (CRT) in women with locally advanced cervical cancer …
[PDF] unil.ch

[PDF][PDF] A PROSPECTIVE PHASE I–II TRIAL OF THE CYCLOOXYGENASE-2 INHIBITOR CELECOXIB IN PATIENTS WITH CARCINOMA OF THE CERVIX WITH …

FG HERRERA, P CHAN, C DOLL… - Int. J. Radiation …, 2007 - serval.unil.ch
Purpose: To evaluate the toxicity and effectiveness of celecoxib in combination with
definitive chemoradiotherapy (CRT) in women with locally advanced cervical cancer …

A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor …

FG Herrera, P Chan, C Doll… - … journal of radiation …, 2007 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate the toxicity and effectiveness of celecoxib in combination with definitive
chemoradiotherapy (CRT) in women with locally advanced cervical cancer. Methods and …
[PDF] unil.ch

[PDF][PDF] A PROSPECTIVE PHASE I–II TRIAL OF THE CYCLOOXYGENASE-2 INHIBITOR CELECOXIB IN PATIENTS WITH CARCINOMA OF THE CERVIX WITH …

FG HERRERA, P CHAN, C DOLL… - Int. J. Radiation …, 2007 - serval.unil.ch
Purpose: To evaluate the toxicity and effectiveness of celecoxib in combination with
definitive chemoradiotherapy (CRT) in women with locally advanced cervical cancer …